4,5-Disubstituted-1,3-oxazolidin-2-imine derivatives: A new class of orally bioavailable nitric oxide synthase inhibitor

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 2, 2004, Pages 313-316

  Ueda, Shigeo ^a   Terauchi, Hideo ^a   Yano, Akihiro ^a   Ido, Motoharu ^a   Matsumoto, Masashi ^a   Kawasaki, Motoji ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

1,3 Oxazolidin 2 imine; Inducible nitric oxide synthase inhibitor; Selectivity

Indexed keywords

1,3 OXAZOLIDIN 2 IMINE; IMINE; NITRIC OXIDE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BIOAVAILABILITY; DRUG EFFECT; ENZYME INHIBITION; IC 50; IN VITRO STUDY; IN VIVO STUDY; STRUCTURE ACTIVITY RELATION;

EID: 0346099292     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.11.010     Document Type: Article

References (26)

1. Palmer R.M.J., Ferrige A.G., Moncada S. Nature. 327:1987;524.
2. Pfeiffer S., Mayer B., Hemmens B. Angew. Chem., Int. Ed. Engl. 38:1999;1714.
3. Marletta M.A. J. Biol. Chem. 268:1993;12231.
4. Stuehr D.J., Griffith O.W. Adv. Enzymol. Relat. Areas Mol. Biol. 65:1992;287.
5. Thiemermann C., Vane J. Eur. J. Pharmacol. 182:1990;591.
6. Grabowski P.S., Wright P.K., Van't Hof R.J., Helfrich M.H., Ohshima H., Ralston S.H. Br. J. Rheumatol. 36:1997;651.
7. Seo H.G., Takata I., Nakamura M., Tatsumi H., Suzuki K., Fujii J., Taniguchi N. Arch. Biochem. Biophys. 324:1995;41.
8. Rees D.D., Palmer R.M.J., Moncada S. Proc. Natl. Acad. Sci. U.S.A. 86:1989;3375.
9. Böhme G.A., Bon C., Lemaire M., Reibaud M., Piot O., Stutzmann J.M., Doble A., Blanchard J.C. Proc. Natl. Acad. Sci. U.S.A. 90:1993;9191.
10. Nakane M., Klinghofer V., Kuk J., Donnelly J., Budzik G., Pollock J., Basha F., Carter G. Mol. Pharmacol. 47:1995;831.
11. Hansen D.W., Peterson K.B., Trivedi M., Webber R.K., Tjoeng F.S., Moore W.M., Jerome G.M., Kornmeier C.M., Manning P.T., Connor J.R., Misko P.T., Currie M.G., Pitzele B.S. J. Med. Chem. 41:1998;1361.
12. Hagmann W.K., Galdwell C.G., Chen P., Durette P.L., Esser C.K., Lanza T.J., Kopka I.E., Guthikonda R., Shah S.K., MacCoss M., Chabin R.M., Fletcher D., Grant S.K., Green B.G., Humes J.L., Kelly T.M., Luell S., Meurer R., Moore V., Pacholok S.G., Pavia T., Williams H.R., Wong K.K. Bioorg. Med. Chem. Lett. 10:2000;1975.
13. Tinker A.C., Beaton H.G., Boughton-Smith N., Cook T.R., Cooper S.L., Fraser-Rae L., Hallam K., Hamley P., McInally T., Nicholls D.J., Pimm A.D., Wallace A.V. J. Med. Chem. 46:2003;913.
14. Naka M., Nanbu T., Kobayashi K., Kamanaka Y., Komeno M., Yanase R., Fukutomi T., Fujimura S., Seo H.G., Fujiwara N., Ohuchida S., Suzuki K., Kondo K., Taniguchi N. Biochem. Biophys. Res. Commun. 270:2000;663.
15. Young R.J., Beams R.M., Carter K., Clark H.A.R., Coe D.M., Chambers C.L., Davies P.I., Dawson J., Drysdale M.J., Franzman K.W., French C., Hodgson S.T., Hodson H.F., Kleanthous S., Rider P., Sanders D., Sawyer D.A., Scott K.J., Shearer B.G., Stocker R., Smith S., Tackley M.C., Knowles R.G. Bioorg. Med. Chem. Lett. 10:2000;597.
16. Reetz M.T., Drewes M.W., Schmitz A. Angew. Chem., Int. Ed. Engl. 26:1987;1141.
17. Andrés J.M., Barrio R., Martínez M.A., Pedrosa R., Pérez-Encabo A. J. Org. Chem. 61:1996;4210.
18. Ponsold K., Ihn W. Tetrahedron Lett. 11:1970;1125.
19. Jung S.H., Kohn H. J. Am. Chem. Soc. 107:1985;2931.
20. Misko T.P., Moore W.M., Kasten T.P., Nickols G.A., Corbette J.A., Tilton R.G., McDaniel M.L., Williamson J.R., Currie M.G. Eur. J. Pharmacol. 233:1993;119.
21. Bredt D.S., Snyder S.H. Proc. Natl. Acad. Sci. U.S.A. 87:1990;682.
22. +.
23. +.
24. Crane B.R., Arvai A.S., Gachhui R., Wu C., Ghosh D.K., Getzoff E.D., Stuehr D.J., Tainer J.A. Science. 278:1997;425.
25. 26.
26. Wang Y.X., Poon C.I., Pang C.C.Y. J. Pharmacol. Exp. Ther. 265:1993;112.